BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 9922587)

  • 1. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
    De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
    Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activator.
    Okada K; Lijnen HR; Moreau H; Vanderschueren S; Collen D
    Thromb Haemost; 1996 Dec; 76(6):857-9. PubMed ID: 8972000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
    Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double bolus of 0.75 MU streptokinase plus enoxaparin versus front-loaded alteplase plus unfractionated heparin in ST-segment elevation myocardial infarction.
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Căpraru P; Guran M; Istrătescu O; Tatu-Chiţoiu A; Bumbu A; Dorobanţu M
    Rom J Intern Med; 2003; 41(4):395-408. PubMed ID: 15526522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase.
    Szabo S; Letsch R; Ehlers R; Walter T; Kazmaier S; Helber U; Hoffmeister HM
    Thromb Res; 2002 Apr; 106(2):113-9. PubMed ID: 12182909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endovenous thrombolysis in acute myocardial infarct. The experience in a community hospital. An analysis of 120 patients].
    Jorge Sdo C
    Arq Bras Cardiol; 1992 Jul; 59(1):23-30. PubMed ID: 1341143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
    Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
    van Griensven JM; Koster RW; Burggraaf J; Huisman LG; Kluft C; Kroon R; Schoemaker RC; Cohen AF
    Clin Pharmacol Ther; 1998 Jan; 63(1):39-47. PubMed ID: 9465840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II).
    Armstrong PW; Burton J; Pakola S; Molhoek PG; Betriu A; Tendera M; Bode C; Adgey AA; Bar F; Vahanian A; Van de Werf F;
    Am Heart J; 2003 Sep; 146(3):484-8. PubMed ID: 12947367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of new thrombolytic substances].
    Zeymer U; Neuhaus KL
    Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
    J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction.
    Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR
    Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
    Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
    Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tissue plasminogen activator (t-PA) in myocardial infarction. Biological aspects].
    Samama M; Verdy E; Conard J; Vahanian A; Michel P; Van Dreden P; Nguyen G; Horellou MH; Combrisson A; Acar J
    Arch Mal Coeur Vaiss; 1986 Oct; 79(11):1618-24. PubMed ID: 3103572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemorrhagic risk in intravenously administered thrombolytic treatment in acute myocardial infarction].
    Acar J; Dorent R; Vahanian A; Michel PL; Cormier B; Slama M; Cazaux P; Conard J; Verdy E; Samama M
    Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():59-65. PubMed ID: 3142430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New substances and dosages for thrombolysis in acute myocardial infarct].
    Zeymer U; Neuhaus KL
    Z Kardiol; 1993; 82 Suppl 2():137-41. PubMed ID: 8328192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.